Schedule 13G ownership disclosure

CYTEIR THERAPEUTICS INC

Security class unavailable · CUSIP: 23284P103

Event date: 2023-11-02

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-23-014535
Form type
SC 13G
Filer
Cyteir Therapeutics, Inc.
CIK
CIK 1662244
Filed
Nov 03, 2023
Reporting period
Nov 02, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub